Moreover, several studies have shown that ITGA3 maintains aberrant expression in various types of cancer, including prostate cancer, intrahepatic cholangiocarcinoma, melanoma, pancreatic cancer, squamous cell carcinoma of the tongue, breast cancer, and colorectal cancer [50,51]. Here, ITGA3 is linked to colorectal cancer.